Stay updated on Nivolumab and SRS in Recurrent Meningioma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page.

Latest updates to the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe webpage has been updated to include new information about the clinical trial for recurrent meningioma, specifically mentioning the use of nivolumab and stereotactic radiosurgery. Additionally, the revision number has been updated to v2.15.0.SummaryDifference43%
- Check37 days agoChange DetectedThe page has been updated to reflect a new version of the content, with the latest update date changed to April 9, 2025, and the revision number updated to v2.14.4. Additionally, the Echocardiography Test has been added to the page.SummaryDifference0.4%
- Check45 days agoChange DetectedThe page has been updated to reflect a new version release, moving from v2.14.2 to v2.14.3, and the last update date has changed from February 28, 2025, to March 25, 2025.SummaryDifference0.1%
- Check74 days agoChange DetectedThe web page has updated its date references, removing older dates and adding new ones for February 2025.SummaryDifference0.2%
- Check81 days agoChange DetectedThe webpage has updated its clinical trial data sharing policies and removed outdated information regarding objective response rates and survival metrics. Additionally, new dates for data sharing plans have been introduced.SummaryDifference2%
Stay in the know with updates to Nivolumab and SRS in Recurrent Meningioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page.